波兰国家免疫规划引入肺炎球菌结合疫苗前社区获得性肺炎住院监测(2009-2016年):一项全国性回顾性数据库分析
该研究利用波兰国家公共卫生研究所的全国公共统计数据,分析2009至2016年肺炎住院率、病原分型及年龄分布趋势,为2017年1月引入肺炎球菌结合疫苗前的基线数据。结果显示肺炎总住院率在325.9至372.2/10万人口之间波动,肺炎链球菌住院率在5岁以下儿童中显著上升,而流感嗜血杆菌肺炎住院率下降,院内死亡从2009年5578例增至2016年8149例,其中85%以上为60岁及以上人群。
要点
- 肺炎总住院率在325.9至372.2/10万人口之间波动,老年人和5岁及以下儿童住院率较高。
- 2009至2016年,肺炎链球菌住院率在<2岁、2-3岁和4-5岁儿童中分别从5.3、5.2、1.9升至12.4、8.2、4.6/10万人口。
- 流感嗜血杆菌肺炎住院率在<2岁和2-3岁儿童中分别从7.8、4.8降至1.8、1.9/10万人口。
核心结论
- 这是波兰首项全国性肺炎住院研究,提供了基线数据,可用于后续调查疫苗接种政策变化对肺炎住院的影响。
研究设计与样本
- 全国性回顾性数据库分析,使用波兰国家公共卫生研究所的全国公共统计数据,按病原和年龄分组分析2009至2016年肺炎住院率和院内死亡率。
主要发现
- 肺炎总住院率在325.9至372.2/10万人口之间波动,老年人和5岁及以下儿童住院率较高。
- 2009至2016年,肺炎链球菌住院率在<2岁、2-3岁和4-5岁儿童中分别从5.3、5.2、1.9升至12.4、8.2、4.6/10万人口。
- 流感嗜血杆菌肺炎住院率在<2岁和2-3岁儿童中分别从7.8、4.8降至1.8、1.9/10万人口。
- 院内死亡从2009年5578例增至2016年8149例,其中85%以上为60岁及以上人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Community-acquired pneumonia (CAP) is a common infection with significant morbidity and mortality. In January 2017, Poland introduced pneumococcal conjugate vaccine (PCV) into their national immunisation programme to protect children against invasive pneumococcal disease. This study was designed to investigate pneumonia-related hospitalisation rates and trends from 2009 to 2016 prior to the introduction of nationally funded PCV vaccination. METHODS: Using national public statistic data available from the National Institute of Public Health - National Institute of Hygiene, annual hospitalisation rates for pneumonia were analysed, categorised by aetiology and age (<2, 2-3, 4-5, 6-19, 20-59, 60+ years). Trends over time were assessed, as well as in-hospital mortality. RESULTS: The overall hospitalisation rate due to pneumonia varied between 325.9 and 372.2/100,000 population. Higher rates of hospitalisation were seen in older adults and children ≤5 years. Trends were observed when analysing hospitalisations by pneumonia aetiology within age groups: between 2009 and 2016, Streptococcus pneumoniae hospitalisations significantly increased for children aged <2, 2-3, and 4-5 years, from 5.3 to 12.4, 5.2 to 8.2, and 1.9 to 4.6/100,000 population respectively. Whereas hospitalisations due to Haemophilus influenzae pneumonia decreased significantly from 7.8 to 1.8 and 4.8 to 1.9/100,000 children aged <2 and 2-3 years respectively. The numbers of in-hospital deaths increased from 5578 in 2009 to 8149 in 2016, with >85% of deaths in the 60+ age group. CONCLUSIONS: This is the first national study of pneumonia hospitalisations in Poland, providing the baseline data from which to investigate the impact of the change in vaccination policy on pneumonia hospitalisations in Poland.
引用
- Gajewska M, Goryński P, Paradowska-Stankiewicz I, et al. Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis. Vaccine. 2019. PMID: 31653527. doi:10.1016/j.vaccine.2019.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。